5-109378457-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_014819.5(PJA2):āc.1030C>Gā(p.Gln344Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000316 in 1,613,966 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 13/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ).
Frequency
Consequence
NM_014819.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
PJA2 | NM_014819.5 | c.1030C>G | p.Gln344Glu | missense_variant | 4/10 | ENST00000361189.7 | NP_055634.3 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
PJA2 | ENST00000361189.7 | c.1030C>G | p.Gln344Glu | missense_variant | 4/10 | 1 | NM_014819.5 | ENSP00000354775.2 | ||
PJA2 | ENST00000361557.4 | c.1030C>G | p.Gln344Glu | missense_variant | 3/9 | 2 | ENSP00000355284.3 |
Frequencies
GnomAD3 genomes AF: 0.0000197 AC: 3AN: 152106Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000598 AC: 15AN: 250766Hom.: 0 AF XY: 0.0000738 AC XY: 10AN XY: 135490
GnomAD4 exome AF: 0.0000328 AC: 48AN: 1461860Hom.: 0 Cov.: 63 AF XY: 0.0000426 AC XY: 31AN XY: 727228
GnomAD4 genome AF: 0.0000197 AC: 3AN: 152106Hom.: 0 Cov.: 32 AF XY: 0.0000269 AC XY: 2AN XY: 74306
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 18, 2023 | The c.1030C>G (p.Q344E) alteration is located in exon 4 (coding exon 3) of the PJA2 gene. This alteration results from a C to G substitution at nucleotide position 1030, causing the glutamine (Q) at amino acid position 344 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at